B2B Supplement Manufacturing FAQs

Please share the dosage form, formula or ingredient list, target serving size, unit count, expected order quantity, packaging preference, destination market and any required certifications. Product references, artwork files or target pricing can also help us recommend a more practical route.

MOQ depends on dosage form, formula, ingredient procurement, packaging structure and production process. Many bottled capsule or gummy projects commonly begin around 1,000 finished units, while softgels, stick packs, blister packs, printed films and custom tooling generally require higher production quantities.

Selected formulas and packaging formats may support a reduced trial quantity, but this must be reviewed against raw-material and packaging minimums. When a lower quantity is not practical, we can suggest a simpler package, an established formula or another dosage form.

An existing formula is usually faster and more cost-efficient for market testing. Custom formulation is more suitable when you need a specific ingredient profile, dose, flavor, claim direction, target cost or competitive positioning.

Yes, but each flavor, strength, formula or packaging design is normally treated as a separate SKU. MOQ, sampling, artwork, testing and production setup are reviewed for each SKU before the final quotation is confirmed.

Our manufacturing network supports capsules, gummies, softgels, powders, tablets and liquid drops. The appropriate facility and production line are selected according to the formula, dosage form, volume, packaging and destination market.

Custom development, sample approval, raw-material procurement, packaging production and bulk manufacturing each have separate lead times. Bulk production commonly requires approximately 15–30 days after all formula, artwork, packaging, payment and material conditions are confirmed, but the final schedule is project-specific.

The production schedule normally begins after the formula and sample are approved, artwork is print-ready, packaging specifications are confirmed, required payment is received and necessary materials are available. Delays in any approval can move the planned production date.

Changes may still be possible before production starts, but they can affect cost, sampling, material orders, print files and lead time. Once raw materials or packaging have entered production, changes may require additional cost or a new production schedule.

Yes. We support repeat production, packaging updates and product-line expansion. Reorder planning is easier when forecasts are shared early, especially for imported ingredients, custom packaging or high-volume projects.

Available documents may include product specifications, batch COA, TDS, SDS, allergen statements, GMO statements, BSE/TSE statements, ingredient documents, microbiological results, heavy-metal results and applicable facility certificates. The exact document set depends on the formula, material and project.

Relevant facilities may hold certifications or programs such as GMP, HACCP, ISO 22000, Halal, Kosher or eligible organic certification. Certification availability and scope must be confirmed for the selected facility, dosage form, formula and destination market.

Yes. Testing can be arranged according to the formula, product type, customer specification and destination-market requirements. Typical testing may include microbiology, heavy metals, active ingredients, contaminants or other project-specific items.

Available support depends on the raw material and supplier documentation. Ingredient-level statements or laboratory testing may be used where appropriate, and any required testing scope should be confirmed before quotation or production.

Shelf life is based on the dosage form, formula, ingredient stability, packaging barrier and available supporting data. Formal stability studies or market-specific validation can be discussed when required by the customer or destination market.